Why the study?
Does an oral fat load unmask catalytic defects in normolipidemic carriers of the Asn291Ser mutation in the LPL gene compared to healthy controls?
Population
9 subjects: 3 unrelated normolipidemic Asn291Ser carriers, 5 healthy controls, and 1 subject with a 50%…
Comparison
Oral fat load vs Healthy controls and a subject with a 50%…
Design
Case-control
Authors
Loading...
Postprandial testing may detect functional LPL impairment in normolipidemic carriers; hypothesis-generating and requires prospective validation before clinical consideration.
Does an oral fat load unmask catalytic defects in normolipidemic carriers of the Asn291Ser mutation in the LPL gene compared to healthy controls?
The Asn291Ser mutation in the LPL gene results in significant disturbances in postprandial chylomicron metabolism following an oral fat load, even in subjects with normal fasting lipid levels.
Pimstone et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: